Additionally, bioinformatics analysis suggests that elevated expression of FAM111B augments sensitivity to chemotherapeutic drugs such as cisplatin, paclitaxel, and gemcitabine—indicating potential therapeutic strategies for targeting FAM111B in cancer treatment. The gene discussed is FAM111B; the disease is cancer.